B. Blechacz, M. Komuta, T. Roskams, and G. J. Gores, Clinical diagnosis and staging of cholangiocarcinoma, Nat Rev Gastroenterol Hepatol. sept, vol.8, issue.9, pp.512-534, 2011.

S. K. Maithel, T. C. Gamblin, I. Kamel, C. P. Corona-villalobos, M. Thomas et al., Multidisciplinary approaches to intrahepatic cholangiocarcinoma, Cancer, vol.15, issue.22, pp.3929-3971, 2013.

Y. H. Shaib, J. A. Davila, K. Mcglynn, and H. B. El-serag, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, J Hepatol. mars, vol.40, issue.3, pp.472-479, 2004.

J. Bridgewater, P. R. Galle, S. A. Khan, J. M. Llovet, J. Park et al., Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, J Hepatol. 1 juin, vol.60, issue.6, pp.1268-89, 2014.

M. N. Mavros, K. P. Economopoulos, V. G. Alexiou, and T. M. Pawlik, Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis, JAMA Surg. juin, vol.149, issue.6, pp.565-74, 2014.

S. Rizvi, S. A. Khan, C. L. Hallemeier, R. K. Kelley, and G. J. Gores, Cholangiocarcinomaevolving concepts and therapeutic strategies, Nat Rev Clin Oncol, vol.15, issue.2, pp.95-111, 2018.

S. M. Weber, D. Ribero, E. M. O'reilly, N. Kokudo, M. Miyazaki et al., Intrahepatic cholangiocarcinoma: expert consensus statement, HPB. août, vol.17, issue.8, pp.669-80, 2015.

A. M. Horgan, E. Amir, T. Walter, and J. J. Knox, Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis, J Clin Oncol Off J Am Soc Clin Oncol. 1 juin, vol.30, issue.16, pp.1934-1974, 2012.

J. T. Miura, F. M. Johnston, S. Tsai, B. George, J. Thomas et al., Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma, Ann Surg Oncol, vol.22, issue.11, pp.3716-3739, 2015.

D. R. Waisberg, R. S. Pinheiro, L. S. Nacif, V. Rocha-santos, R. B. Martino et al., Resection for intrahepatic cholangiocellular cancer: new advances, Transl Gastroenterol Hepatol, vol.3, p.60, 2018.

G. Spolverato, Y. Kim, S. Alexandrescu, H. P. Marques, J. Lamelas et al., Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection, Ann Surg Oncol. janv, vol.23, issue.1, pp.235-278, 2016.

R. M. Dodson, M. J. Weiss, D. Cosgrove, J. M. Herman, I. Kamel et al.,

, Intrahepatic cholangiocarcinoma: management options and emerging therapies

, J Am Coll Surg, vol.217, issue.4, pp.736-750, 2013.

J. M. Banales, V. Cardinale, G. Carpino, M. Marzioni, J. B. Andersen et al., Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA), Nat Rev Gastroenterol Hepatol, vol.13, issue.5, pp.261-80, 2016.

G. C. Farrell and C. Z. Larter, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatol Baltim Md. févr, vol.43, issue.2, pp.99-112, 2006.

Z. M. Younossi, A. B. Koenig, D. Abdelatif, Y. Fazel, L. Henry et al., Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatol Baltim Md, vol.64, issue.1, pp.73-84, 2016.

M. E. Rinella, Nonalcoholic fatty liver disease: a systematic review, JAMA. 9 juin, vol.313, issue.22, pp.2263-73, 2015.

G. C. Farrell, V. Wong, and S. Chitturi, NAFLD in Asia--as common and important as in the West, Nat Rev Gastroenterol Hepatol. mai, vol.10, issue.5, pp.307-325, 2013.

H. Yki-järvinen, Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome, Lancet Diabetes Endocrinol, vol.2, issue.11, pp.901-911, 2014.

G. A. Michelotti, M. V. Machado, A. M. Diehl, . Nafld, and . Cancer, Nat Rev Gastroenterol Hepatol, vol.10, issue.11, pp.656-65, 2013.

B. Mohamad, V. Shah, M. Onyshchenko, M. Elshamy, F. Aucejo et al.,

, Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis, Hepatol Int. juill, vol.10, issue.4, pp.632-641, 2016.

T. M. Welzel, B. I. Graubard, S. Zeuzem, H. B. El-serag, J. A. Davila et al.,

, Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database, Hepatol Baltim Md. août, vol.54, issue.2, pp.463-71, 2011.

S. K. Reddy, J. W. Marsh, P. R. Varley, B. K. Mock, K. B. Chopra et al.,

, Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study, Hepatol Baltim Md. déc, vol.56, issue.6, pp.2221-2251, 2012.

N. Wongjarupong, B. Assavapongpaiboon, P. Susantitaphong, and C. ,

W. , T. S. Rerknimitr, and R. , Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis, BMC Gastroenterol. 8 déc, vol.17, issue.1, p.149, 2017.

F. Cauchy, D. Fuks, Z. Le-bian, A. Belghiti, J. Costi et al., Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: The new scourges?, World J Hepatol. 27 mai, vol.6, issue.5, pp.306-320, 2014.

T. Wakai, Y. Shirai, J. Sakata, P. V. Korita, Y. Ajioka et al.,

, Gastrointest Surg Off J Soc Surg Aliment Tract. août, vol.15, issue.8, pp.1450-1458, 2011.

N. Chalasani, Z. Younossi, J. E. Lavine, M. Charlton, K. Cusi et al., The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the, Hepatol Baltim Md, vol.67, issue.1, pp.328-57, 2018.

, EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease, European Association for the Study of the Liver (EASL), vol.64, pp.1388-402, 2016.

A. J. Sanyal, E. M. Brunt, D. E. Kleiner, K. V. Kowdley, N. Chalasani et al.,

, Endpoints and clinical trial design for nonalcoholic steatohepatitis, Hepatol Baltim Md. juill, vol.54, issue.1, pp.344-53, 2011.

P. Bedossa, . Flip-pathology, and . Consortium, Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

, Hepatol Baltim Md. août, vol.60, issue.2, pp.565-75, 2014.

D. E. Kleiner, E. M. Brunt, M. Van-natta, C. Behling, M. J. Contos et al., Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatol Baltim Md. juin, vol.41, issue.6, pp.1313-1334, 2005.

C. Couinaud, Liver anatomy: portal (and suprahepatic) or biliary segmentation

, Dig Surg, vol.16, issue.6, pp.459-67, 1999.

D. Dindo, N. Demartines, and P. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey

, Ann Surg. août, vol.240, issue.2, pp.205-218, 2004.

C. Estes, H. Razavi, R. Loomba, Z. Younossi, and A. J. Sanyal, Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease, Hepatol Baltim Md, vol.67, issue.1, pp.123-156, 2018.

V. Paradis, S. Zalinski, E. Chelbi, N. Guedj, F. Degos et al.,

, Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis, Hepatol Baltim Md. mars, vol.49, issue.3, pp.851-860, 2009.

I. Mikolasevic, S. Milic, T. Turk-wensveen, I. Grgic, I. Jakopcic et al.,

, Nonalcoholic fatty liver disease -A multisystem disease?, World J Gastroenterol, vol.22, issue.43, pp.9488-505, 2016.

H. Fotbolcu and E. Zorlu, Nonalcoholic fatty liver disease as a multi-systemic disease, World J Gastroenterol. 28 avr, vol.22, issue.16, pp.4079-90, 2016.

A. Kurmann, B. Wanner, F. Martens, J. Klasen, F. Stickel et al., Hepatic steatosis is associated with surgical-site infection after hepatic and colorectal surgery, Surgery. juill, vol.156, issue.1, pp.109-125, 2014.

C. P. Neal, C. D. Mann, E. Pointen, A. Mcgregor, G. Garcea et al., Influence of hepatic parenchymal histology on outcome following right hepatic trisectionectomy, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.16, issue.11, pp.2064-73, 2012.

S. Agrawal and C. Daruwala, Metabolic syndrome and hepatic resection: improving outcome, HPB. déc, vol.13, issue.12, pp.846-59, 2011.

Y. X. Koh, H. J. Tan, Y. X. Liew, N. Syn, J. Y. Teo et al., Liver Resection for

, Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma, J Am Coll Surg. 6 août, 2019.

B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, P. M. Schlag et al.,

, Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, Lancet Lond Engl. 22 mars, vol.371, issue.9617, pp.1007-1023, 2008.

P. Clavien, H. Petrowsky, M. L. Deoliveira, and R. Graf, Strategies for safer liver surgery and partial liver transplantation, N Engl J Med. 12 avr, vol.356, issue.15, pp.1545-59, 2007.

L. Lin, H. Kuo, J. Hwang, L. Lai, F. Chiang et al., Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents, Atherosclerosis. avr, vol.203, issue.2, pp.563-571, 2009.

Y. Chang, S. Ryu, Y. Zhang, H. J. Son, J. Kim et al., A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers, PloS One, vol.7, issue.5, p.37241, 2012.

M. Kwak, D. Kim, G. E. Chung, S. J. Kang, M. J. Park et al., Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease, Clin Mol Hepatol. déc, vol.18, issue.4, pp.383-90, 2012.

C. Hobeika, F. Cauchy, N. Poté, P. Rautou, F. Durand et al., Shortand Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome, World J Surg, vol.43, issue.8, pp.2048-60, 2019.

R. Kwok, K. C. Choi, G. Wong, Y. Zhang, H. Chan et al., Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study, Gut, vol.65, issue.8, pp.1359-68, 2016.

T. Nishioka, S. Kubo, S. Tanaka, K. Wakasa, S. Takemura et al.,

, Outcomes of Hepatic Resection in Intrahepatic Cholangiocarcinoma Patients with Diabetes, Hypertension, and Dyslipidemia: Significance of Routine Follow

, Liver Cancer. avr, vol.5, issue.2, pp.107-127, 2016.

M. A. Türko?lu, Y. Yamamoto, T. Sugiura, Y. Okamura, T. Ito et al., The favorable prognosis after operative resection of hypervascular intrahepatic cholangiocarcinoma: A clinicopathologic and immunohistochemical study, Surgery, vol.160, issue.3, pp.683-90, 2016.

S. Ariizumi, Y. Kotera, Y. Takahashi, S. Katagiri, I. Chen et al.,

S. Aishima, T. Iguchi, Y. Nishihara, N. Fujita, K. Taguchi et al.,

, Decreased intratumoral arteries reflect portal tract destruction and aggressive characteristics in intrahepatic cholangiocarcinoma, Histopathology. mars, vol.54, issue.4, pp.452-61, 2009.

J. Xu, S. Igarashi, M. Sasaki, T. Matsubara, N. Yoneda et al., Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers, Liver Int Off J Int Assoc Study Liver. août, vol.32, issue.7, 2012.

, Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study, Lancet Oncol. mai, vol.20, issue.5, pp.663-73, 2019.

J. Edeline, M. Benabdelghani, A. Bertaut, J. Watelet, P. Hammel et al.,

, Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study, J Clin Oncol Off J Am Soc Clin Oncol. 10 mars, vol.37, issue.8, pp.658-67, 2019.

A. Doussot, C. Lim, C. Gómez-gavara, D. Fuks, O. Farges et al.,

, Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma, Br J Surg, vol.103, issue.13, pp.1887-94, 2016.

C. H. Lieu, L. A. Renfro, A. De-gramont, J. P. Meyers, and T. S. Maughan,

, Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program, J Clin Oncol Off J Am Soc Clin Oncol. 20 sept, vol.32, issue.27, pp.2975-84, 2014.

O. Hyder, H. Marques, C. Pulitano, J. W. Marsh, S. Alexandrescu et al.,

, A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience, JAMA Surg. mai, vol.149, issue.5, pp.432-440, 2014.

O. Hyder, I. Hatzaras, G. C. Sotiropoulos, A. Paul, S. Alexandrescu et al., Recurrence after operative management of intrahepatic cholangiocarcinoma, Surgery. juin, vol.153, issue.6, pp.811-819, 2013.

Y. Wang, J. Li, Y. Xia, R. Gong, K. Wang et al., Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy, J Clin Oncol Off J Am Soc Clin Oncol. 20 mars, vol.31, issue.9, pp.1188-95, 2013.

D. Ribero, A. D. Pinna, A. Guglielmi, A. Ponti, G. Nuzzo et al., Surgical Approach for Long-term Survival of Patients With Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis of 434 Patients, Arch Surg Chic Ill, vol.147, issue.12, pp.1107-1120, 1960.

W. Jiang, Z. Zeng, Z. Tang, F. J. Sun, H. Zhou et al., A prognostic scoring system based on clinical features of intrahepatic cholangiocarcinoma: the Fudan score, Ann Oncol Off J Eur Soc Med Oncol. juill, vol.22, issue.7, pp.1644-52, 2011.

O. Farges, D. Fuks, E. Boleslawski, L. Treut, Y. Castaing et al., Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group, Ann Surg, vol.254, issue.5, pp.824-833, 2011.

M. C. De-jong, H. Nathan, G. C. Sotiropoulos, A. Paul, S. Alexandrescu et al., Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment, J Clin Oncol Off J Am Soc Clin Oncol. 10 août, vol.29, issue.23, pp.3140-3145, 2011.

S. Bennett, L. Baker, R. Shorr, G. Martel, and D. Fergusson, The impact of perioperative red blood cell transfusions in patients undergoing liver resection: a systematic review protocol, Syst Rev. 29 févr, vol.5, p.38, 2016.

X. Zhang, Q. Chen, C. W. Kimbrough, E. W. Beal, Y. Lv et al.,

I. Lymphadenectomy-for and . Cholangiocarcinoma, Has Nodal Evaluation Been Increasingly Adopted by Surgeons over Time?A National Database Analysis

, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.22, issue.4, pp.668-75, 2018.

F. Bagante, G. Spolverato, M. Weiss, S. Alexandrescu, H. P. Marques et al., Assessment of the Lymph Node Status in Patients Undergoing Liver Resection for Intrahepatic Cholangiocarcinoma: the New Eighth Edition AJCC Staging System, J Gastrointest Surg Off J Soc Surg Aliment Tract, vol.22, issue.1, pp.52-61, 2018.

A. Vitale, M. Moustafa, G. Spolverato, F. Gani, U. Cillo et al., Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma, J Surg Oncol. mai, vol.113, issue.6, pp.685-91, 2016.

D. H. Kim, D. W. Choi, S. H. Choi, J. S. Heo, and A. Kow, Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution, Surgery. avr, vol.157, issue.4, pp.666-75, 2015.

J. Hu, F. Chen, K. Zhou, C. Zhou, Y. Cao et al., Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection, Oncotarget. 26 déc, vol.8, issue.69, pp.113817-113844, 2017.

G. Nkontchou, T. Van-nhieu, J. Ziol, M. Tengher, I. Mahmoudi et al., Peripheral intrahepatic cholangiocarcinoma occurring in patients without cirrhosis or chronic bile duct diseases: epidemiology and histopathology of distant nontumoral liver in 57 White patients, Eur J Gastroenterol Hepatol. janv, vol.25, issue.1, pp.94-102, 2013.